Minimizing Patient Burden Through the Use of Historical Subject-Level Data in Innovative Confirmatory Clinical Trials: Review of Methods and Opportunities
Open Access
- 1 September 2018
- journal article
- review article
- Published by Springer Nature in Therapeutic Innovation & Regulatory Science
- Vol. 52 (5) , 546-559
Abstract
The goal of clinical trial research is to deliver safe and efficacious new treatments to patients in need in a timely and cost-effective manner. There is precedent in using historical control data to reduce the number of concurrent control subjects required in developing medicines for rare diseases and other areas of unmet need. The purpose of this paper is to provide a review for a regulatory and industry audience of the current state of relevant statistical methods, and of the uptake of these approaches and the opportunities for broader use of historical data in confirmatory clinical trials. General principles to consider when incorporating historical control data in a new trial are presented. Bayesian and frequentist approaches are outlined including how the operating characteristics for such a trial can be obtained. Finally, examples of approved new treatments that incorporated historical controls in their confirmatory trials are presented.Keywords
This publication has 62 references indexed in Scilit:
- Predicting the extent of heterogeneity in meta-analysis, using empirical data from the Cochrane Database of Systematic ReviewsInternational Journal of Epidemiology, 2012
- The Cochrane Collaboration's tool for assessing risk of bias in randomised trialsBMJ, 2011
- An Introduction to Propensity Score Methods for Reducing the Effects of Confounding in Observational StudiesMultivariate Behavioral Research, 2011
- Optimal caliper widths for propensity‐score matching when estimating differences in means and differences in proportions in observational studiesPharmaceutical Statistics, 2011
- Type I error rate control in adaptive designs for confirmatory clinical trials with treatment selection at interimPharmaceutical Statistics, 2011
- Summarizing historical information on controls in clinical trialsClinical Trials, 2010
- Diagnosis, symptoms, frequency and mortality of 260 patients with urea cycle disorders from a 21‐year, multicentre study of acute hyperammonaemic episodesActa Paediatrica, 2008
- The design of simulation studies in medical statisticsStatistics in Medicine, 2006
- Variable Selection for Propensity Score ModelsAmerican Journal of Epidemiology, 2006
- The central role of the propensity score in observational studies for causal effectsBiometrika, 1983